Correlation Between Pulmatrix and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and ABVC Biopharma, you can compare the effects of market volatilities on Pulmatrix and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and ABVC Biopharma.

Diversification Opportunities for Pulmatrix and ABVC Biopharma

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pulmatrix and ABVC is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Pulmatrix i.e., Pulmatrix and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Pulmatrix and ABVC Biopharma

Given the investment horizon of 90 days Pulmatrix is expected to generate 0.63 times more return on investment than ABVC Biopharma. However, Pulmatrix is 1.59 times less risky than ABVC Biopharma. It trades about 0.05 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.03 per unit of risk. If you would invest  384.00  in Pulmatrix on August 29, 2024 and sell it today you would earn a total of  350.00  from holding Pulmatrix or generate 91.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pulmatrix  vs.  ABVC Biopharma

 Performance 
       Timeline  
Pulmatrix 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pulmatrix and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmatrix and ABVC Biopharma

The main advantage of trading using opposite Pulmatrix and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Pulmatrix and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stocks Directory
Find actively traded stocks across global markets